Veterinary Pharmacovigilance Market Is Slated To Witness Tremendous Growth In Future Veterinary Pharmacovigilance

Rahul Nikade

Right Now

Veterinary Pharmacovigilance Market Is Slated To Witness Tremendous Growth In Future

Veterinary Pharmacovigilance Industry

The global veterinary pharmacovigilance market size is expected to reach USD 1.91 billion by 2030, registering a compound annual growth rate (CAGR) of 13.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market growth is driven by several factors, including the increasing incidence of adverse drug reactions in animals, the rising adoption of companion animals, and the growing demand for animal-derived food products. Additionally, increasing regulatory scrutiny and the need for stringent safety standards have spurred the development of new pharmacovigilance technologies and tools. Companies such as Accenture offer a range of veterinary vigilance services, including ICSR case processing, VeDDRA coding, signal detection, literature management, EvVetMPD support, and regulatory intelligence. The growing industry requirements for aggregate reporting, expedited reporting, and signal management are also expected to propel market growth in the coming years.

The COVID-19 pandemic had both negative and positive effects on the animal health market. While it created challenges, it also opened opportunities for companies to adapt and innovate, highlighting the importance of monitoring the safety and efficacy of animal health products during global health crises. This situation boosted awareness and adoption of veterinary pharmacovigilance solutions. Veterinary pharmacovigilance is an emerging sector within the broader animal healthcare market. It involves monitoring the safety and effectiveness of veterinary medicines, vaccines, and other animal health products, along with reporting any adverse reactions or incidents that may occur. This information is utilized to enhance the safety and quality of animal health products and to protect animal welfare. With increasing concern for animal welfare and the rising demand for animal-based food products, the market has garnered significant attention in recent years.

Initiatives by key market players are also contributing to market growth. For example, in June 2018, Medfiles opened a new office in Japan to serve European and Japanese clients with a variety of services, including pharmacovigilance, clinical trials, and analytical services. Similarly, in February 2022, Ennov, another major market participant, opened a new office in the U.S. following its successful growth in the North American market. This expansion enhanced the company’s global footprint with a focus on strengthening its pharmacovigilance capabilities. Ennov’s pharmacovigilance offerings include case intake, triage, signal detection, and management, catering to customers from both human and veterinary life sciences markets.

Curious about the Veterinary Pharmacovigilance Market, Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Veterinary Pharmacovigilance Market Segments Highlights:

One of the key trends in the veterinary pharmacovigilance market is the adoption of new technologies such as electronic reporting systems and data analytics tools. These technologies allow for more efficient and accurate monitoring of adverse events, and can help to identify potential safety issues before they become more serious.
The software segment dominated the global veterinary pharmacovigilance industry and accounted for the largest revenue share of 51.0% in 2024
By product, anti-infectives held the largest share of over 45.4% of the market in 2024. Biologics segment on the other hand, is estimated to grow at the highest rate of over 14% over the next few years.
The in-house segment led the market with the largest revenue share of 54.4% in 2024
Dogs in veterinary pharmacovigilance industry held the dominant position with the highest revenue share of 50.0% in 2024
North America dominated the market by region in 2024 with a share of about 40%. Asia Pacific region is estimated to grow at the fastest rate of over 15.4% from 2025 to 2030.
The veterinary pharmacovigilance market presents significant opportunities for companies that are able to innovate, differentiate themselves, and respond to the evolving needs of the animal health industry.

Veterinary Pharmacovigilance Market Report Segmentation

Grand View Research has segmented the global veterinary pharmacovigilance market report based on solution, type, product, animal type, and region:

Veterinary Pharmacovigilance Solution Outlook (Revenue, USD Million, 2018 - 2030)